Gene-Guided diabetes care put to the test in 500-Patient trial
NCT ID NCT06851962
First seen Mar 06, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study tests whether choosing diabetes medications based on a person's genetic profile works better than standard care for controlling blood sugar. About 500 adults aged 40-70 with poorly controlled type 2 diabetes will receive either gene-guided or standard treatment. Researchers will compare how many reach their blood sugar goal and track any side effects over 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Clínico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital General Universitario de Valencia (HGUV)
Valencia, 46014, Spain
-
Hospital Universitario Regional de Málaga
Málaga, 29010, Spain
Conditions
Explore the condition pages connected to this study.